Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Intelligent Bio Solutions Inc.

NASDAQ: INBS · Industrial Applications and Services · 4 alerts · CIK 1725430

Share price
$1.50Close, Nov 16
Market cap
$4.98M
Shares outstanding
3.32MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Intelligent Bio Solutions Inc. filings on SEC EDGAR ↗

4:31 PM ET 8-K
Financial Results

Intelligent Bio Solutions Financial Results

Intelligent Bio Solutions reported record fiscal first quarter 2027 revenue of $1.39 million, a 25% increase year-over-year, driven by higher-margin cartridge sales. The company also achieved a significant regulatory milestone by submitting its FDA 510(k) premarket notification for its fingerprinting drug screening system, targeting the U.S. market.

Term
Q1 2027

“Fiscal first quarter revenue was the highest quarterly revenue in our Company’s history. Each reader draws on a recurring supply of higher-margin cartridges, which is driving most of our revenue growth. Our business continues to scale with improving unit economics, including expanding gross profit margins driven by manufacturing efficiencies and a higher share of revenue from higher-margin cartridge consumables.”

Harry Simeonidis, President and CEO

“In September, we submitted our 510(k) premarket notification to the FDA for the Intelligent Fingerprinting Drug Screening System, the culmination of the clinical program we executed throughout 2026 and a key step toward our planned entry into the multi-billion-dollar U.S. drug screening market. Going forward, we will continue to invest in the clinical and regulatory work behind our 510(k) submission while maintaining discipline across the rest of the business.”

Harry Simeonidis, President and CEO
8:32 AM ET 10-Q
Financial Results

Intelligent Bio Solutions Q1 2026 Results: Net Loss of $2.66M, Loss Narrows

Intelligent Bio Solutions Inc. reported a net loss of $2.67 million for the quarter ended September 30, 2026, an improvement from the $2.99 million loss in the prior year. Revenue grew 25% to $1.39 million, while the company strengthened its liquidity position with cash and cash equivalents increasing to $5.93 million, primarily through financing activities.

Key figure
Net loss $2.66M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.